Home > Archive>Volume 11, Issue 8, 2018 >1430-1432. DOI:10.18240/ijo.2018.08.29
PDF HTML XML Export Cite reminder
A challenging case of tuberculosis-associated uveitis after corticosteroid treatment for Vogt-Koyanagi-Harada disease
Author:
Corresponding Author:

Su-Qin Yu. Department of Ophthalmology, Shanghai General Hospital, No.100, Haining Road, Shanghai 200080, China. sq-yu@163.com

  • Article
    • | |
  • Metrics
    • |
  • Reference [12]
    • |
  • Related [20]
    • | | |
  • Comments
    Reference
    1 Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res 2016;52:84-111.
    2 Neves A, Cardoso A, Almeida M, Campos J, Campos A, Castro Sousa JP. Unilateral Vogt-Koyanagi-Harada disease: a clinical case report. Case Rep Ophthalmol 2015;6(3):361-365.
    3 Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131(5):647-652.
    4 Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology 2007;114(3):606-614.
    5 Kalogeropoulos D, Kitsos G, Konstantinidis A, Gartzonika C, Svarna E, Malamos K, Katsanevakis E, Kalogeropoulos C. Tuberculous posterior sclero-uveitis with features of Vogt-Koyanagi-Harada uveitis: an unusual case. Am J Case Rep 2017;18:367-374.
    6 Moorthy RS, Inomata H, Rao NA. Vogt-koyanagi-harada syndrome. Surv Ophthalmol 1995;39(4):265-292.
    7 Read RW, Yu F, Accorinti M, et al. Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2006;142(1):119-124.
    8 Latronico ME, Rigante D, Caso F, Cantarini L, Costa L, Nieves-Martín L, Traversi C, Franceschini R. Bilateral dexamethasone intravitreal implant in a young patient with Vogt-Koyanagi-Harada disease and refractory uveitis. Clin Rheumatol 2015;34(6):1145-1148.
    9 Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use, other associated factors, and the risk of tuberculosis. Arthritis Rheum 2006;55(1):19-26.
    10 Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG. Prevention and management of glucocorticoid-induced side effects: a comprehensive review: infectious complications and vaccination recommendations. J Am Acad Dermatol 2017;76(2):191-198.
    11 Bovornkitti S, Kangsadal P, Sathirapat P, Oonsombatti P. Reversion and reconversion rate of tuberculin skin reactions in correlation with the use of prednisone. Dis Chest 1960;38(1):51-55.
    12 Schatz M, Patterson R, Kloner R, Falk J. The prevalence of tuberculosis and positive tuberculin skin tests in a steroid-treated asthmatic population. Ann Intern Med 1976;84(3):261-265.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Tian-Wei Qian, Su-Qin Yu, Xun Xu. ,/et al.A challenging case of tuberculosis-associated uveitis after corticosteroid treatment for Vogt-Koyanagi-Harada disease. Int J Ophthalmol, 2018,11(8):1430-1432

Copy
Share
Article Metrics
  • Abstract:1352
  • PDF: 650
  • HTML: 342
  • Cited by: 0
Publication History
  • Received:February 23,2018
  • Revised:May 25,2018
  • Online: August 07,2018
You are the 4483662 Visitors
Governing Body：Department of Health, Provincial Government of Shaanxi, China
Organizer：Xi'an Medical Association of China
Address：Room 11707-08, Building 2, Unit 1, Wanda Plaza, No.8 Yanta North Road, Xi'an 710054, Shaanxi Province, China
Fax：(8629)82245172 Phone：(+8629)82245172/82210956
Email：ijopress@163.com
International Journal of Ophthalmology ® 2025 All Rights Reserved   The terms of CC BY-NC-ND 4.0 are applicable to all open access content.